These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23591705)

  • 1. Cigarette smoking and clopidogrel interaction.
    Swiger KJ; Yousuf O; Bliden KP; Tantry US; Gurbel PA
    Curr Cardiol Rep; 2013 May; 15(5):361. PubMed ID: 23591705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study.
    Gurbel PA; Bliden KP; Logan DK; Kereiakes DJ; Lasseter KC; White A; Angiolillo DJ; Nolin TD; Maa JF; Bailey WL; Jakubowski JA; Ojeh CK; Jeong YH; Tantry US; Baker BA
    J Am Coll Cardiol; 2013 Aug; 62(6):505-12. PubMed ID: 23602770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet adenosine diphosphate receptor antagonists: ticlopidine to ticagrelor-a long continuing journey.
    Kaul U; Mansoor AH
    Indian Heart J; 2012; 64(1):54-9. PubMed ID: 22572427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ticagrelor: a P2Y12 antagonist for use in acute coronary syndromes.
    Wijeyeratne YD; Joshi R; Heptinstall S
    Expert Rev Clin Pharmacol; 2012 May; 5(3):257-69. PubMed ID: 22697589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of platelet function testing to guide therapy in clopidogrel low and enhanced responders.
    Bernlochner I; Byrne RA; Kastrati A; Sibbing D
    Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):999-1014. PubMed ID: 21878045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ticagrelor versus clopidogrel in Chinese patients with acute coronary syndrome: A pharmacodynamic analysis.
    Chen Y; Dong W; Wan Z; Li Z; Cong H; Hong T; Yin T
    Int J Cardiol; 2015 Dec; 201():545-6. PubMed ID: 26325437
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative pharmacokinetics and pharmacodynamics of platelet adenosine diphosphate receptor antagonists and their clinical implications.
    Floyd CN; Passacquale G; Ferro A
    Clin Pharmacokinet; 2012 Jul; 51(7):429-42. PubMed ID: 22568693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic, pharmacodynamic and pharmacogenetic profile of the oral antiplatelet agent ticagrelor.
    Teng R
    Clin Pharmacokinet; 2012 May; 51(5):305-18. PubMed ID: 22489610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developments in Oral Antiplatelet Agents for the Treatment of Acute Coronary Syndromes: Clopidogrel, Prasugrel, and Ticagrelor.
    Roffman DS
    J Pharm Pract; 2016 Jun; 29(3):239-49. PubMed ID: 25660584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and Clopidogrel.
    Geisler T; Booth J; Tavlaki E; Karathanos A; Müller K; Droppa M; Gawaz M; Yanez-Lopez M; Davidson SJ; Stables RH; Banya W; Zaman A; Flather M; Dalby M
    PLoS One; 2015; 10(8):e0135037. PubMed ID: 26317618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High on-treatment platelet reactivity and P2Y12 antagonists in clinical trials.
    Trenk D; Kristensen SD; Hochholzer W; Neumann FJ
    Thromb Haemost; 2013 May; 109(5):834-45. PubMed ID: 23238773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study.
    Ueno M; Ferreiro JL; Desai B; Tomasello SD; Tello-Montoliu A; Capodanno D; Capranzano P; Kodali M; Dharmashankar K; Charlton RK; Bass TA; Angiolillo DJ
    JACC Cardiovasc Interv; 2012 Mar; 5(3):293-300. PubMed ID: 22440495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of platelet inhibitor treatment.
    Trenk D; Hochholzer W
    Br J Clin Pharmacol; 2014 Apr; 77(4):642-53. PubMed ID: 23981082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latest evidence in personalized antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
    Uhry S; Bessereau J; Camoin-Jau L; Paganelli F; Bonello L
    Hosp Pract (1995); 2012 Apr; 40(2):104-17. PubMed ID: 22615085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy.
    Hochholzer W; Trenk D; Mega JL; Morath T; Stratz C; Valina CM; O'Donoghue ML; Bernlochner I; Contant CF; Guo J; Sabatine MS; Schömig A; Neumann FJ; Kastrati A; Wiviott SD; Sibbing D
    Am Heart J; 2011 Sep; 162(3):518-26.e5. PubMed ID: 21884870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive comparative review of adenosine diphosphate receptor antagonists.
    Oh EY; Abraham T; Saad N; Rapp JH; Vastey FL; Balmir E
    Expert Opin Pharmacother; 2012 Feb; 13(2):175-91. PubMed ID: 22216937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prasugrel hydrochloride for the treatment of acute coronary syndromes.
    Lhermusier T; Waksman R
    Expert Opin Pharmacother; 2015 Mar; 16(4):585-96. PubMed ID: 25633751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticagrelor: an investigational oral antiplatelet treatment for reduction of major adverse cardiac events in patients with acute coronary syndrome.
    Abergel E; Nikolsky E
    Vasc Health Risk Manag; 2010 Oct; 6():963-77. PubMed ID: 21057581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel.
    Roe MT; Goodman SG; Ohman EM; Stevens SR; Hochman JS; Gottlieb S; Martinez F; Dalby AJ; Boden WE; White HD; Prabhakaran D; Winters KJ; Aylward PE; Bassand JP; McGuire DK; Ardissino D; Fox KA; Armstrong PW
    Circulation; 2013 Aug; 128(8):823-33. PubMed ID: 23852610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching antiplatelet regimens: alternatives to clopidogrel in patients with acute coronary syndrome undergoing PCI: a review of the literature and practical considerations for the interventional cardiologist.
    Azmoon S; Angiolillo DJ
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):232-42. PubMed ID: 22581463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.